Colorectal cancer: Current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation

World Journal of Gastroenterology

Volumn 19, Issue 46, 2013, Pages 8502-8514

  Kekelidze, Maka ^a   D'Errico, Luigia ^a   Pansini, Michele ^a   Tyndall, Anthony ^a   Hohmann, Joachim ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Colorectal cancer; Computed tomography; Contrast enhanced ultrasound; Diffusion weighted imaging; Imaging; Magnetic resonance imaging; Staging

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COLONOSCOPY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; ECHOGRAPHY; FIBROSIS; FOLLOW UP; HUMAN; METASTASIS; MULTICENTER STUDY (TOPIC); NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SOLID TUMOR; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

COLORECTAL CANCER; COMPUTED TOMOGRAPHY; CONTRAST ENHANCED ULTRASOUND; DIFFUSION WEIGHTED IMAGING; IMAGING; MAGNETIC RESONANCE IMAGING; STAGING;

COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; ENDOSONOGRAPHY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 84890348435     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i46.8502     Document Type: Article

References (81)

1. Barish MA, Soto JA, Ferrucci JT. Consensus on current clinical practice of virtual colonoscopy. AJR Am J Roentgenol 2005; 184: 786-792 PMID: 15728598 DOI: 10.2214/ ajr.184.3.01840786]
2. Vogl TJ, Schmiegel W, Pox C, Pereira PL, Brambs HJ, Lux P, Fischer S. S3 guideline--Diagnosis and treatment of colorectal carcinoma: relevance for radiologic imaging and interventions. Rofo 2013; 185: 699-708 PMID: 23804154 DOI: 10.1055/s-0033-1335818]
3. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-364 PMID: 12594673 DOI: 10.1002/bjs.4034]
4. Torigian DA, Huang SS, Houseni M, Alavi A. Functional imaging of cancer with emphasis on molecular techniques. CA Cancer J Clin 2007; 57: 206-224 PMID: 17626118]
5. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504 PMID: 11229667]
6. Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 2010; 257: 674-684 PMID: 20829538 DOI: 10.1148/ radiol.10100729]
7. Minicozzi A, Mosconi E, Cordiano C, Rubello D, Marzola P, Ferretti A, Maffione AM, Sboarina A, Bencivenga M, Boschi F, Conti G, Sbarbati A. Proton magnetic resonance spectroscopy: ex vivo study to investigate its prognostic role in colorectal cancer. Biomed Pharmacother 2013; 67: 593-597 PMID: 23830479 DOI: 10.1016/j.biopha.2013.05.002]
8. Goh V, Shastry M, Engledow A, Kozarski R, Peck J, Endozo R, Rodriguez-Justo M, Taylor SA, Halligan S, Groves AM. Integrated (18)F-FDG PET/CT and perfusion CT of primary colorectal cancer: effect of interand intraobserver agreement on metabolic-vascular parameters. AJR Am J Roentgenol 2012; 199: 1003-1009 PMID: 23096172 DOI: 10.2214/AJR.11.7823]
9. Leen E, Goldberg JA, Angerson WJ, McArdle CS. Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet 2000; 355: 34-37 PMID: 10615889]
10. Hohmann J, Müller C, Oldenburg A, Skrok J, Frericks BB, Wolf KJ, Albrecht T. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers. Ultrasound Med Biol 2009; 35: 1427-1435 PMID: 19540656 DOI: 10.1016/j.ultrasmedbio.2009.04.002]
11. Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696 PMID: 22356322 DOI: 10.1056/NEJMoa1100370]
12. Shah HA, Paszat LF, Saskin R, Stukel TA, Rabeneck L. Factors associated with incomplete colonoscopy: a populationbased study. Gastroenterology 2007; 132: 2297-2303 PMID: 17570204 DOI: 10.1053/j.gastro.2007.03.032]
13. Anderson JC, Messina CR, Cohn W, Gottfried E, Ingber S, Bernstein G, Coman E, Polito J. Factors predictive of difficult colonoscopy. Gastrointest Endosc 2001; 54: 558-562 PMID: 11677470]
14. Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200 PMID: 14657426 DOI: 10.1056/NEJMoa031618]
15. Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, Zfass A, Wright AR, Iyer RB, Lynch P, Sivak MV, Butler H. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. JAMA 2004; 291: 1713-1719 PMID: 15082698 DOI: 10.1001/jama.291.14.1713]
16. Atkin W, Halligan S. Computed tomographic colonography for colorectal cancer diagnosis Authors' reply. Lancet 2013; 382: 125 PMID: 23849919 DOI: 10.1016/ S0140-6736(13)61558-5]
17. Taylor SA, Laghi A, Lefere P, Halligan S, Stoker J. European Society of Gastrointestinal and Abdominal Radiology (ES-GAR): consensus statement on CT colonography. Eur Radiol 2007; 17: 575-579 PMID: 16967260 DOI: 10.1007/s00330-0060407-y]
18. de Haan MC, van Gelder RE, Graser A, Bipat S, Stoker J. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a metaanalysis. Eur Radiol 2011; 21: 1747-1763 PMID: 21455818 DOI: 10.1007/s00330-011-2104-8]
19. Halligan S, Altman DG, Taylor SA, Mallett S, Deeks JJ, Bartram CI, Atkin W. CT colonography in the detection of colorectal polyps and cancer: systematic review, metaanalysis, and proposed minimum data set for study level reporting. Radiology 2005; 237: 893-904 PMID: 16304111 DOI: 10.1148/radiol.2373050176]
20. Hartmann D, Bassler B, Schilling D, Adamek HE, Jakobs R, Pfeifer B, Eickhoff A, Zindel C, Riemann JF, Layer G. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology 2006; 238: 143-149 PMID: 16304088 DOI: 10.1148/radiol.2381041756]
21. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-1474 PMID: 20180029 DOI: 10.1245/s10434-010-0985-4]
22. Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, Nordlinger B, van de Velde CJ, Balmana J, Regula J, Nagtegaal ID, Beets-Tan RG, Arnold D, Ciardiello F, Hoff P, Kerr D, Köhne CH, Labianca R, Price T, Scheithauer W, Sobrero A, Tabernero J, Aderka D, Barroso S, Bodoky G, Douillard JY, El Ghazaly H, Gallardo J, Garin A, GlynneJones R, Jordan K, Meshcheryakov A, Papamichail D, Pfeiffer P, Souglakos I, Turhal S, Cervantes A. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol 2012; 23: 2479-2516 PMID: 23012255 DOI: 10.1093/annonc/mds236]
23. Glimelius B, Beets-Tan R, Blomqvist L, Brown G, Nagtegaal I, Påhlman L, Quirke P, Valentini V, van de Velde C. Mesorectal fascia instead of circumferential resection margin in preoperative staging of rectal cancer. J Clin Oncol 2011; 29: 2142-2143 PMID: 21502560 DOI: 10.1200/JCO.2010.34.4473]
24. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004; 232: 335-346 PMID: 15286305 DOI: 10.1148/radiol.2322021326]
25. Blomqvist L, Machado M, Rubio C, Gabrielsson N, Granqvist S, Goldman S, Holm T. Rectal tumour staging: MR imaging using pelvic phased-array and endorectal coils vs endoscopic ultrasonography. Eur Radiol 2000; 10: 653-660 PMID: 10795550]
26. Maldjian C, Smith R, Kilger A, Schnall M, Ginsberg G, Kochman M. Endorectal surface coil MR imaging as a staging technique for rectal carcinoma: a comparison study to rectal endosonography. Abdom Imaging 2000; 25: 75-80 PMID: 10652927]
27. Bipat S, Niekel MC, Comans EF, Nio CY, Bemelman WA, Verhoef C, Stoker J. Imaging modalities for the staging of patients with colorectal cancer. Neth J Med 2012; 70: 26-34 PMID: 22271811]
28. Lahaye MJ, Engelen SM, Nelemans PJ, Beets GL, van de Velde CJ, van Engelshoven JM, Beets-Tan RG. Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR 2005; 26: 259-268 PMID: 16152740]
29. Tsunoda Y, Ito M, Fujii H, Kuwano H, Saito N. Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol 2008; 38: 347-353 PMID: 18424814 DOI: 10.1093/jjco/hyn032]
30. Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, Giovagnoni A. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 2010; 31: 19-31 PMID: 20027569 DOI: 10.1002/jmri.22010]
31. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007; 6: 43-52 PMID: 17510541]
32. Parnaby CN, Bailey W, Balasingam A, Beckert L, Eglinton T, Fife J, Frizelle FA, Jeffery M, Watson AJ. Pulmonary staging in colorectal cancer: a review. Colorectal Dis 2012; 14: 660-670 PMID: 21689294 DOI: 10.1111/j.1463-1318.2011.02601.x]
33. Kim HY, Lee SJ, Lee G, Song L, Kim SA, Kim JY, Chang DK, Rhee PL, Kim JJ, Rhee JC, Chun HK, Kim YH. Should Preoperative Chest CT Be Recommended to All Colon Cancer Patients? Ann Surg 2013 Feb 19; Epub ahead of print PMID: 23426347 DOI: 10.1097/SLA.0b013e3182865080]
34. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Carpi A, Nicolini A, Mandoliti G, Polico C. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother 2004; 58: 451-457 PMID: 15464875 DOI: 10.1016/j.biopha.2004.08.005]
35. Suppiah A, Hunter IA, Cowley J, Garimella V, Cast J, Hartley JE, Monson JR. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis 2009; 11: 249-253 PMID: 18513192 DOI: 10.1111/j.1463-1318.2008.01593.x]
36. Vanagunas A, Lin DE, Stryker SJ. Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am J Gastroenterol 2004; 99: 109-112 PMID: 14687151]
37. Sun YS, Zhang XP, Tang L, Ji JF, Gu J, Cai Y, Zhang XY. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254: 170-178 PMID: 20019139 DOI: 10.1148/radiol.2541082230]
38. Hein PA, Kremser C, Judmaier W, Griebel J, Pfeiffer KP, Kreczy A, Hug EB, Lukas P, DeVries AF. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003; 45: 214-222 PMID: 12595106]
39. Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI. Locally advanced rectal cancer: added value of diffusionweighted MR imaging in the evaluation of tumor response to neoadjuvant chemoand radiation therapy. Radiology 2009; 253: 116-125 PMID: 19789256 DOI: 10.1148/radiol.2532090027]
40. Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, Haustermans K, Valentini V, Beets GL, Beets-Tan RG. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol 2011; 18: 2224-2231 PMID: 21347783 DOI: 10.1245/s10434-011-1607-5]
41. van der Paardt MP, Zagers MB, Beets-Tan RG, Stoker J, Bipat S. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and metaanalysis. Radiology 2013; 269: 101-112 PMID: 23801777 DOI: 10.1148/radiol.13122833]
42. Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009; 11: 102-125 PMID: 19186405]
43. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248: 894-900 PMID: 18710982 DOI: 10.1148/radiol.2483071407]
44. Flamen P, Stroobants S, Van Cutsem E, Dupont P, Bormans G, De Vadder N, Penninckx F, Van Hoe L, Mortelmans L. Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer. J Clin Oncol 1999; 17: 894-901 PMID: 10071281]
45. Figueiras RG, Goh V, Padhani AR, Naveira AB, Caamaño AG, Martin CV. The role of functional imaging in colorectal cancer. AJR Am J Roentgenol 2010; 195: 54-66 PMID: 20566797 DOI: 10.2214/AJR.10.4422]
46. Konski A, Li T, Sigurdson E, Cohen SJ, Small W, Spies S, Yu JQ, Wahl A, Stryker S, Meropol NJ. Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation. Int J Radiat Oncol Biol Phys 2009; 74: 55-59 PMID: 19004571 DOI: 10.1016/j.ijrobp.2008.07.050]
47. Kalff V, Ware R, Heriot A, Chao M, Drummond E, Hicks RJ. Radiation changes do not interfere with postchemoradiation restaging of patients with rectal cancer by FDG PET/CT before curative surgical therapy. Int J Radiat Oncol Biol Phys 2009; 74: 60-66 PMID: 18922649 DOI: 10.1016/ j.ijrobp.2008.06.1944]
48. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000; 41: 1369-1379 PMID: 10945530]
49. Kiviet AM, Mji A. Sex differences in self-efficacy beliefs of elementary science teachers. Psychol Rep 2003; 92: 333-338 PMID: 12674301]
50. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002; (1): CD002200 PMID: 11869629 DOI: 10.1002/14651858.CD002200]
51. Mitry E, Guiu B, Cosconea S, Jooste V, Faivre J, Bouvier AM. Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study. Gut 2010; 59: 1383-1388 PMID: 20732912 DOI: 10.1136/ gut.2010.211557]
52. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228-247 PMID: 19097774 DOI: 10.1016/j.ejca.2008.10.026]
53. Esteves FP, Schuster DM, Halkar RK. Gastrointestinal tract malignancies and positron emission tomography: an overview. Semin Nucl Med 2006; 36: 169-181 PMID: 16517238 DOI: 10.1053/j.semnuclmed.2005.12.002]
54. Will O, Purkayastha S, Chan C, Athanasiou T, Darzi AW, Gedroyc W, Tekkis PP. Diagnostic precision of nanoparticleenhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol 2006; 7: 52-60 PMID: 16389184 DOI: 10.1016/ S1470-2045(05)70537-4]
55. Bellomi M, Petralia G, Sonzogni A, Zampino MG, Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 2007; 244: 486-493 PMID: 17641369 DOI: 10.1148/radiol.2442061189]
56. Sahani DV, Kalva SP, Hamberg LM, Hahn PF, Willett CG, Saini S, Mueller PR, Lee TY. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 2005; 234: 785-792 PMID: 15734934 DOI: 10.1148/radiol.2343040286]
57. George ML, Dzik-Jurasz AS, Padhani AR, Brown G, Tait DM, Eccles SA, Swift RI. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001; 88: 1628-1636 PMID: 11736977 DOI: 10.1046/j.0007-1323.2001.01947.x]
58. Ng F, Ganeshan B, Kozarski R, Miles KA, Goh V. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 2013; 266: 177-184 PMID: 23151829 DOI: 10.1148/radiol.12120254]
59. Ridge JA, Bading JR, Gelbard AS, Benua RS, Daly JM. Perfusion of colorectal hepatic metastases. Relative distribution of flow from the hepatic artery and portal vein. Cancer 1987; 59: 1547-1553 PMID: 3828954]
60. Ballantyne KC, Charnley RM, Perkins AC, Pye G, Whalley DR, Wastie ML, Hardcastle JD. Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun 1990; 11: 23-28 PMID: 2338966]
61. Cooke DA, Parkin A, Wiggins P, Robinson PJ, Giles GR. Hepatic perfusion index and the evolution of liver metastases. Nucl Med Commun 1987; 8: 970-972 PMID: 3449792]
62. Nott DM, Grime SJ, Yates J, Day DW, Baxter JN, Jenkins SA, Cooke TG. Changes in the hepatic perfusion index during the development of experimental hepatic tumours. Br J Surg 1989; 76: 259-263 PMID: 2720322]
63. Kruskal JB, Thomas P, Kane RA, Goldberg SN. Hepatic perfusion changes in mice livers with developing colorectal cancer metastases. Radiology 2004; 231: 482-490 PMID: 15128993]
64. Yarmenitis SD, Kalogeropoulou CP, Hatjikondi O, Ravazoula P, Petsas T, Siamblis D, Kalfarentzos F. An experimental approach of the Doppler perfusion index of the liver in detecting occult hepatic metastases: histological findings related to the hemodynamic measurements in Wistar rats. Eur Radiol 2000; 10: 417-424 PMID: 10756988]
65. Leen E, Angerson WJ, Wotherspoon H, Moule B, Cook TG, McArdle CS. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology 1995; 195: 113-116 PMID: 7892449]
66. Glover C, Douse P, Kane P, Karani J, Meire H, Mohammadtaghi S, Allen-Mersh TG. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum 2002; 45: 476-484 PMID: 12006929]
67. Roumen RM, Scheltinga MR, Slooter GD, van der Linden AW. Doppler perfusion index fails to predict the presence of occult hepatic colorectal metastases. Eur J Surg Oncol 2005; 31: 521-527 PMID: 15922888]
68. Bang N, Nielsen MB, Rasmussen AN, Osterhammel PA, Pedersen JF. Hepatic vein transit time of an ultrasound contrast agent: simplified procedure using pulse inversion imaging. Br J Radiol 2001; 74: 752-755 PMID: 11511501]
69. Albrecht T, Blomley MJ, Cosgrove DO, Taylor-Robinson SD, Jayaram V, Eckersley R, Urbank A, Butler-Barnes J, Patel N. Transit-time studies with levovist in patients with and without hepatic cirrhosis: a promising new diagnostic tool. Eur Radiol 1999; 9 Suppl 3: S377-S381 PMID: 10602933]
70. Lim AK, Taylor-Robinson SD, Patel N, Eckersley RJ, Goldin RD, Hamilton G, Foster GR, Thomas HC, Cosgrove DO, Blomley MJ. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54: 128-133 PMID: 15591518]
71. Zhang H, He Y, Du L, Wu Y. Shorter hepatic transit time can suggest coming metastases: through-monitoring by contrastenhanced ultrasonography? J Ultrasound Med 2010; 29: 719-726 PMID: 20427783]
72. Haendl T, Strobel D, Neureiter D, Esser K, Frieser M, Hahn EG, Bernatik T. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls]. Ultraschall Med 2010; 31: 582-588 PMID: 20183780 DOI: 10.1055/ s-0028-1109953]
73. Bernatik T, Becker D, Neureiter D, Hänsler JH, Frieser M, Schaber S, Wein A, Hahn EG, Strobel D. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol 2004; 16: 313-317 PMID: 15195896]
74. Shi GF, Wang SJ, Wang Q, Xu Q, Li RX, Du Y, Wang YN, Li YK, Yang L, Zhang JJ. [Effect of perfusion CT scan on hepatic hemodynamic changes in rats with liver micrometastases]. Ai Zheng 2006; 25: 849-854 PMID: 16831276]
75. Wright KC, Ravoori MK, Dixon KA, Han L, Singh SP, Liu P, Gupta S, Johnson VE, Kan Z, Kundra V. Perfusion CT assessment of tissue hemodynamics following hepatic arterial infusion of increasing doses of angiotensin II in a rabbit liver tumor model. Radiology 2011; 260: 718-726 PMID: 21633050 DOI: 10.1148/radiol.11101868]
76. Kanematsu M, Goshima S, Watanabe H, Kondo H, Kawada H, Noda Y, Moriyama N. Diffusion/perfusion MR imaging of the liver: practice, challenges, and future. Magn Reson Med Sci 2012; 11: 151-161 PMID: 23037559]
77. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003; 229: 409-414 PMID: 12970464 DOI: 10.1148/radiol.2292021128]
78. Hohmann J, Newerla C, Müller A, Reinicke C, Skrok J, Frericks BB, Albrecht T. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers. J Magn Reson Imaging 2012; 36: 1389-1394 PMID: 22893441 DOI: 10.1002/jmri.23772]
79. Hagiwara M, Rusinek H, Lee VS, Losada M, Bannan MA, Krinsky GA, Taouli B. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology 2008; 246: 926-934 PMID: 18195377 DOI: 10.1148/radiol.2463070077]
80. Rao SX, Chen CZ, Liu H, Zeng MS, Qu XD. Three-dimensional whole-liver perfusion magnetic resonance imaging in patients with hepatocellular carcinomas and colorectal hepatic metastases. BMC Gastroenterol 2013; 13: 53 PMID: 23530688 DOI: 10.1186/1471-230x-13-53]
81. Edrei Y, Gross E, Corchia N, Abramovitch R. Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice. Br J Cancer 2012; 107: 658-666 PMID: 22805330 DOI: 10.1038/bjc.2012.322]